These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19118545)

  • 1. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
    Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
    Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model.
    Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats].
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis.
    Park JH; Jo JH; Kim KH; Kim SJ; Lee WR; Park KK; Park JB
    J Gene Med; 2009 Sep; 11(9):824-33. PubMed ID: 19554625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides.
    Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus.
    Osako MK; Tomita N; Nakagami H; Kunugiza Y; Yoshino M; Yuyama K; Tomita T; Yoshikawa H; Ogihara T; Morishita R
    J Gene Med; 2007 Sep; 9(9):812-9. PubMed ID: 17640082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.
    Ogushi I; Iimuro Y; Seki E; Son G; Hirano T; Hada T; Tsutsui H; Nakanishi K; Morishita R; Kaneda Y; Fujimoto J
    Hepatology; 2003 Aug; 38(2):335-44. PubMed ID: 12883477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N; Morishita R; Tomita S; Gibbons GH; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau VJ
    Gene Ther; 2000 Aug; 7(15):1326-32. PubMed ID: 10918504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis.
    Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of peripheral inflammation in sensory ganglia by nuclear factor (kappa)B decoy oligodeoxynucleotide: involvement of SRC kinase pathway.
    Igwe OJ
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):114-9. PubMed ID: 15882800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
    Lu JP; Sun H; Cao CC; Ou ZL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.
    D'Acquisto F; Ialenti A; Ianaro A; Di Vaio R; Carnuccio R
    Gene Ther; 2000 Oct; 7(20):1731-7. PubMed ID: 11083494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
    Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
    Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of NF-kappaB decoy oligodeoxynucleotides into macrophages reduces murine fatal liver failure after excessive hepatectomy.
    Takahashi T; Togo S; Kumamoto T; Watanabe K; Kubota T; Ichikawa Y; Endo I; Kunisaki C; Nagashima Y; Fujimoto J; Shimada H
    J Surg Res; 2009 Jun; 154(2):179-86. PubMed ID: 19041101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia.
    Qiu J; Hu X; Nesic O; Grafe MR; Rassin DK; Wood TG; Perez-Polo JR
    J Neurosci Res; 2004 Jul; 77(1):108-18. PubMed ID: 15197744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.